The emerging roles and mechanism of m6a in breast cancer progression

Breast cancer (BC) has continued to be the leading cause of cancer deaths in women, accompanied by highly molecular heterogeneity. N6-methyladenosine (m6A), a methylation that happens on adenosine N6, is the most abundant internal mRNA modification type in eukaryotic cells. Functionally, m6A methyla...

Full description

Bibliographic Details
Main Authors: Mengying Zhou, Menglu Dong, Xue Yang, Jun Gong, Xinghua Liao, Qi Zhang, Zeming Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.983564/full
_version_ 1811309239819304960
author Mengying Zhou
Menglu Dong
Xue Yang
Jun Gong
Xinghua Liao
Qi Zhang
Zeming Liu
author_facet Mengying Zhou
Menglu Dong
Xue Yang
Jun Gong
Xinghua Liao
Qi Zhang
Zeming Liu
author_sort Mengying Zhou
collection DOAJ
description Breast cancer (BC) has continued to be the leading cause of cancer deaths in women, accompanied by highly molecular heterogeneity. N6-methyladenosine (m6A), a methylation that happens on adenosine N6, is the most abundant internal mRNA modification type in eukaryotic cells. Functionally, m6A methylation is a reversible modification process and is regulated by 3 enzymes with different functions, namely “writer”, “reader”, and “eraser”. Abnormal m6A modifications trigger the expression, activation, or inhibition of key signaling molecules in critical signaling pathways and the regulatory factors acting on them in BC. These m6A-related enzymes can not only be used as markers for accurate diagnosis, prediction of prognosis, and risk model construction, but also as effective targets for BC treatment. Here, we have emphasized the roles of different types of m6A-related enzymes reported in BC proliferation, invasion, and metastasis, as well as immune regulation. The comprehensive and in-depth exploration of the molecular mechanisms related to m6A will benefit in finding effective potential targets and effective stratified management of BC.
first_indexed 2024-04-13T09:38:42Z
format Article
id doaj.art-37ea9c69b8e34fd593ad5cee5d208d65
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-13T09:38:42Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-37ea9c69b8e34fd593ad5cee5d208d652022-12-22T02:52:01ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-08-011310.3389/fgene.2022.983564983564The emerging roles and mechanism of m6a in breast cancer progressionMengying Zhou0Menglu Dong1Xue Yang2Jun Gong3Xinghua Liao4Qi Zhang5Zeming Liu6Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, ChinaDepartment of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Biliary-Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaInstitute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Wuhan, ChinaDepartment of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBreast cancer (BC) has continued to be the leading cause of cancer deaths in women, accompanied by highly molecular heterogeneity. N6-methyladenosine (m6A), a methylation that happens on adenosine N6, is the most abundant internal mRNA modification type in eukaryotic cells. Functionally, m6A methylation is a reversible modification process and is regulated by 3 enzymes with different functions, namely “writer”, “reader”, and “eraser”. Abnormal m6A modifications trigger the expression, activation, or inhibition of key signaling molecules in critical signaling pathways and the regulatory factors acting on them in BC. These m6A-related enzymes can not only be used as markers for accurate diagnosis, prediction of prognosis, and risk model construction, but also as effective targets for BC treatment. Here, we have emphasized the roles of different types of m6A-related enzymes reported in BC proliferation, invasion, and metastasis, as well as immune regulation. The comprehensive and in-depth exploration of the molecular mechanisms related to m6A will benefit in finding effective potential targets and effective stratified management of BC.https://www.frontiersin.org/articles/10.3389/fgene.2022.983564/fullbreast cancerM6Amethylationgene expressionmiRNAmetastasis
spellingShingle Mengying Zhou
Menglu Dong
Xue Yang
Jun Gong
Xinghua Liao
Qi Zhang
Zeming Liu
The emerging roles and mechanism of m6a in breast cancer progression
Frontiers in Genetics
breast cancer
M6A
methylation
gene expression
miRNA
metastasis
title The emerging roles and mechanism of m6a in breast cancer progression
title_full The emerging roles and mechanism of m6a in breast cancer progression
title_fullStr The emerging roles and mechanism of m6a in breast cancer progression
title_full_unstemmed The emerging roles and mechanism of m6a in breast cancer progression
title_short The emerging roles and mechanism of m6a in breast cancer progression
title_sort emerging roles and mechanism of m6a in breast cancer progression
topic breast cancer
M6A
methylation
gene expression
miRNA
metastasis
url https://www.frontiersin.org/articles/10.3389/fgene.2022.983564/full
work_keys_str_mv AT mengyingzhou theemergingrolesandmechanismofm6ainbreastcancerprogression
AT mengludong theemergingrolesandmechanismofm6ainbreastcancerprogression
AT xueyang theemergingrolesandmechanismofm6ainbreastcancerprogression
AT jungong theemergingrolesandmechanismofm6ainbreastcancerprogression
AT xinghualiao theemergingrolesandmechanismofm6ainbreastcancerprogression
AT qizhang theemergingrolesandmechanismofm6ainbreastcancerprogression
AT zemingliu theemergingrolesandmechanismofm6ainbreastcancerprogression
AT mengyingzhou emergingrolesandmechanismofm6ainbreastcancerprogression
AT mengludong emergingrolesandmechanismofm6ainbreastcancerprogression
AT xueyang emergingrolesandmechanismofm6ainbreastcancerprogression
AT jungong emergingrolesandmechanismofm6ainbreastcancerprogression
AT xinghualiao emergingrolesandmechanismofm6ainbreastcancerprogression
AT qizhang emergingrolesandmechanismofm6ainbreastcancerprogression
AT zemingliu emergingrolesandmechanismofm6ainbreastcancerprogression